![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Bhatia S, Louie AD, Bhatia R et al. 2001. Solid cancers after bone marrow transplantation. Journal of Clinical Oncology 19:464–471.
- Cortes J, O’Brien S, Kantarjian H. 2004. Discontinuation of imatinib therapy after achieving a molecular response. Blood 104:2204–2205.
- Hellstrom AC, Sigurjonson T, Pettersson F. 2001. Carcinoma of the cervical stump. The radiumhemmet series 1959–1987. Treatment and prognosis. Acta Obstetricia et Gynecologica Scandinavica 80:152–157.
- Kolb HJ, Socie G, Duell T et al. 1999. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Annals of Internal Medicine 131:738–744.
- Roy L, Guilhot J, Martineau G et al. 2005. Unexpected occurrence of second malignancies in patients treated with interferon followed by imatinib mesylate for chronic myelogenous leukemia. Leukemia 19:1689–1692.